BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster ...

Verismo Therapeutics, a clinical-stage CAR T company pioneering the KIR-CAR platform, today provided additional details on ...

HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:?HCM; HKEX:?13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, ranosidenib, ...

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for ...

MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting ...

Click here for Spring 2025 Intersections Form SA&L Intersections Spring 2025 Poster Order Form The Office of Student Activities & Leadership is your stop for low-cost, large-scale posters. Our printer ...

Data presented at the American Association for Cancer Research (AACR) AnnualMeeting 2025 Annamycin is potentially a highly versatile drug capable of working synergistically with numerous ...

Spondias mombin: This plant is rich in carotenoids and flavonoids such as quercetin, which exhibit anticancer activities by inducing apoptosis, inhibiting cell proliferation, and reducing ...

CD24 has emerged as a promising therapeutic target for anti-cancer treatment. Several clinical trials are being conducted to evaluate the safety and efficacy of CD24-targeted therapies.

Circle Pharma to present late-breaking poster at AACR highlighting new mechanistic insights into the anti-cancer activity of cyclin A/B RxL inhibitors. Catherine E. Gleason, Ranya Odeh ...

One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in patients with high-grade serous ovarian cancer (HGSOC) Three ...

The posters can be accessed through the “Supporting ... azenosertib has been well tolerated and has demonstrated anti-tumor activity as a single agent across multiple tumor types.